GLP-1 shortage history

2 of the 4 GLP-1 molecules GLP Chart tracks carry no record at all in the FDA shortage database, according to GLP Chart, checked September 3, 2026.

The numbers

  • 2 of the 4 GLP-1 molecules GLP Chart tracks carry no record at all in the FDA shortage database. (openFDA drug shortages API, https://api.fda.gov/drug/shortages.json, September 3, 2026)
  • semaglutide carries 3 FDA shortage records: To Be Discontinued (3). (openFDA drug shortages API, June 4, 2026)
  • liraglutide carries 11 FDA shortage records: Current (9); To Be Discontinued (2). (openFDA drug shortages API, August 27, 2026)
  • The database was read on September 3, 2026. (openFDA drug shortages API, September 3, 2026)
Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.

FDA shortage records, by molecule

MoleculeFDA recordsStatusFDA last updatedNote
semaglutide3To Be Discontinued (3)2026-06-04-
tirzepatide0--No record in the FDA shortage database.
liraglutide11Current (9); To Be Discontinued (2)2026-08-27-
dulaglutide0--No record in the FDA shortage database.

Download this table: CSV or JSON. Free to reuse under CC BY 4.0 with a link. Nothing to sign up for.

Cite or embed this

GLP-1 shortage history, GLP Chart, September 4, 2026. glpchart.com/stats/glp1-shortage-history/

<a href="https://glpchart.com/stats/glp1-shortage-history/">GLP-1 shortage history</a>. Data: GLP Chart, September 4, 2026

Prices behind these figures come from each program's own published pricing page, checked every Monday. The current numbers live on the price index, and the dated monthly release is the GLP-1 Cash Price Index, September 2026. For any other cut of the data, email press@glpchart.com and you will have it within 24 hours.

The other statistics pages